WIRE — Following REJURAN's TGA approval in 2023, the company hosted scientific sessions and a clinical masterclass for Australian healthcare professionals. GANGNEUNG, South Korea, Aug. 13, 2026 /PRNewswire/ -- PharmaResearch, the biopharmaceutical company behind REJURAN, recently participated in Aesthetics 2026, an international... The post Bringing K-Aesthetics to Australia: PharmaResearch Showcases REJURAN® at Aesthetics 2026 appeared first on Kosmo Digital.
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.